The promise and limitations of anti-inflammatory agents for the treatment of Major Depressive Disorder

From inflammation to sickness and depression: when the immune system subjugates the brain

Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · see citing works

Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association

Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · see citing works

A Meta-Analysis of Cytokines in Major Depression

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · see citing works

The role of inflammation in depression: from evolutionary imperative to modern treatment target

Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · see citing works

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766 · see citing works

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression: The Role of Baseline Inflammatory Biomarkers

Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · see citing works

Immune modulation of learning, memory, neural plasticity and neurogenesis

Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483 · see citing works

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder

Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129 · see citing works

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · see citing works

Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior

Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000 · see citing works

Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA

Dyall, S. C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00052 · Cited by 943 · see citing works

Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941 · see citing works

Mechanisms of Action of (n-3) Fatty Acids,

Calder, P. C. (2012) · Journal of Nutrition · doi:10.3945/jn.111.155259 · Cited by 871 · see citing works

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794 · see citing works

The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

Müller, N., & Schwarz, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002006 · Cited by 670 · see citing works

Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis

Kreisel, T., Frank, M. G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M. V., Maier, S. F., & Yirmiya, R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.155 · Cited by 663 · see citing works

Clinical trial of adjunctive Celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

Akhondzadeh, S., Jafari, S., Raisi, F., Nasehi, A. A., Ghoreishi, A., Salehi, B., Mohebbi-Rasa, S., Raznahan, M., & Kamalipour, A. (2009) · Depression and Anxiety · doi:10.1002/da.20589 · Cited by 397 · see citing works

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study

Abbasi, S.-H., Hosseini, F., Modabbernia, A., Ashrafi, M., & Akhondzadeh, S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.033 · Cited by 344 · see citing works

Association Between Depression and Elevated C-Reactive Protein

Danner, M., Kasl, S. V., Abramson, J. L., & Vaccarino, V. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000041542.29808.01 · Cited by 341 · see citing works

Association of high-sensitivity C-reactive protein with <i>de novo</i> major depression

Pasco, J. A., Nicholson, G. C., Williams, L. J., Jacka, F. N., Henry, M. J., Kotowicz, M. A., Schneider, H. G., Leonard, B. E., & Berk, M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076430 · Cited by 321 · see citing works

Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy

Raison, C. L., Borisov, A. S., Broadwell, S. D., Capuron, L., Woolwine, B. J., Jacobson, I. M., Nemeroff, C. B., & Miller, A. H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0106 · Cited by 298 · see citing works

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double‐blind, randomized, placebo‐controlled study

Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta‐Soares, G. B., Frey, B. N., Bowden, C. L., & Soares, J. C. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.912 · Cited by 298 · see citing works

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

Bloch, M. H., & Hannestad, J. O. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.100 · Cited by 293 · see citing works

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

Warner-Schmidt, J. L., Vanover, K. E., Chen, E. Y., Marshall, J. J., & Greengard, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104836108 · Cited by 291 · see citing works

Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder

Mocking, R. J. T., Harmsen, I. M., Assies, J., Koeter, M. W. J., Ruhé, H. G., & Schene, A. H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.29 · Cited by 280 · see citing works

Sex Differences in Depressive and Socioemotional Responses to an Inflammatory Challenge: Implications for Sex Differences in Depression

Moieni, M., Irwin, M. R., Jevtic, I., Olmstead, R., Breen, E. C., & Eisenberger, N. I. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.17 · Cited by 273 · see citing works

Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study

Rapaport, M. H., Nierenberg, A. A., Schettler, P. J., Kinkead, B. L., Cardoos, A., Walker, R., & Mischoulon, D. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.22 · Cited by 271 · see citing works

Depression, Inflammation, and Incident Cardiovascular Disease in Women With Suspected Coronary Ischemia

Vaccarino, V., Johnson, B. D., Sheps, D. S., Reís, S. E., Kelsey, S. F., Bittner, V., Rutledge, T., Shaw, L. J., Sopko, G. S., & Merz, C. N. B. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.069 · Cited by 263 · see citing works

The Anti-Inflammatory Effects of Prostaglandins

Scher, J. U., & Pillinger, M. H. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31819aaa76 · Cited by 259 · see citing works

Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: A double-blind, randomized and placebo-controlled trial

Moshiri, E., Basti, A. A., Noorbala, A.-A., Jamshidi, A. H., Abbasi, S. H., & Akhondzadeh, S. (2006) · Phytomedicine · doi:10.1016/j.phymed.2006.08.006 · Cited by 237 · see citing works

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

Langley, R. G. B., Feldman, S. R., Han, C., Schenkel, B., Szapary, P. O., Hsu, M.-C., Ortonne, J. P., Gordon, K. B., & Kimball, A. B. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.09.014 · Cited by 218 · see citing works

Anti-inflammatory agents in the treatment of bipolar depression: A systematic review and meta-analysis

Rosenblat, J. D., Kakar, R., Berk, M., Kessing, L. V., Vinberg, M., Baune, B. T., Mansur, R. B., Brietzke, E., Goldstein, B. I., & McIntyre, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12373 · Cited by 199 · see citing works

The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial

Menter, A., Augustin, M., Signorovitch, J., Yu, A. P., Wu, E. Q., Gupta, S. R., Bao, Y., & Mulani, P. M. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.07.022 · Cited by 197 · see citing works

Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study

Panagiotakos, D. B. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.01.018 · Cited by 194 · see citing works

Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing

Mostafavi, S., Battle, A., Zhu, X., Potash, J. B., Weissman, M. M., Shi, J., Beckman, K., Haudenschild, C., McCormick, C., Mei, R., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.161 · Cited by 187 · see citing works

The Association Between C-Reactive Protein Levels and Depression: Results from the Northern Finland 1966 Birth Cohort Study

Liukkonen, T., Silvennoinen-Kassinen, S., Jokelainen, J., Räsänen, P., Leinonen, M., Meyer-Rochow, V. B., & Timonen, M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.016 · Cited by 163 · see citing works

Loss of Cadherin-11 Adhesion Receptor Enhances Plastic Changes in Hippocampal Synapses and Modifies Behavioral Responses

Manabe, T., Togashi, H., Uchida, N., Suzuki, S. C., Hayakawa, Y., Yamamoto, M., Yoda, H., Miyakawa, T., Takeichi, M., & Chisaka, O. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0849 · Cited by 154 · see citing works

Effect of Adjunctive l -Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype

Papakostas, G. I., Shelton, R. C., Zajecka, J., Bottiglieri, T., Roffman, J. L., Cassiello-Robbins, C. F., Stahl, S. M., & D, M. F. M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08947 · Cited by 139 · see citing works

Cytokine-induced depression during IFN-α treatment: The role of IL-6 and sleep quality

Prather, A. A., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.07.001 · Cited by 139 · see citing works

Risk for Depression During Interferon-Alpha Treatment Is Affected by the Serotonin Transporter Polymorphism

Lotrich, F. E., Ferrell, R. E., Rabinovitz, M., & Pollock, B. G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.009 · Cited by 136 · see citing works

Trajectories of Depression Severity in Clinical Trials of Duloxetine

Gueorguieva, R. V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.132 · Cited by 114 · see citing works

NSAIDs Are Associated with Lower Depression Scores in Patients with Osteoarthritis

Iyengar, R. L., Gandhi, S., Aneja, A., Thorpe, K. E., Razzouk, L., Greenberg, J., Mosovich, S., & Farkouh, M. E. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.02.037 · Cited by 106 · see citing works

Celecoxib or Naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial

Fields, C., Drye, L., Vaidya, V., & Lyketsos, C. (2012) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318227f4da · Cited by 96 · see citing works

High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania

Huang, T.-L., & Lin, F.-C. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.09.010 · Cited by 90 · see citing works

Influence of continuous infusion of interleukin-1β on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression

Anisman, H., Gibb, J., & Hayley, S. P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1166-z · Cited by 83 · see citing works

Omega-3 Polyunsaturated Fatty Acids Enhance Neuronal Differentiation in Cultured Rat Neural Stem Cells

Katakura, M., Hashimoto, M., Okui, T., Shahdat, H. M., Matsuzaki, K., & Shido, O. (2013) · Stem Cells International · doi:10.1155/2013/490476 · Cited by 80 · see citing works

Major depression during interferon-α treatment: vulnerability and prevention

Lotrich, F. E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.4/felotrich · Cited by 71 · see citing works

Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression

Bauer, J., Hohagen, F., Gimmel, E., Bruns, F., Lis, S., Krieger, S., Ambach, W., Guthmann, A., Grunze, H., Fritsch-Montero, R., et al. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00374-x · Cited by 68 · see citing works

Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment

Franzen, P. L., Buysse, D. J., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.02.011 · Cited by 62 · see citing works

Aspirin for treatment of lithium‐associated sexual dysfunction in men: randomized double‐blind placebo‐controlled study

Saroukhani, S., Emami‐Parsa, M., Modabbernia, A., Ashrafi, M., Farokhnia, M., Hajiaghaee, R., & Akhondzadeh, S. (2013) · Bipolar Disorders · doi:10.1111/bdi.12108 · Cited by 59 · see citing works

Serotonergic and noradrenergic function in depression: clinical correlates

Duval, F., Mokrani, M., Bailey, P., Corrêa, H., Crocq, M., Diep, T. S., & Macher, J.-P. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.3/fduval · Cited by 12 · see citing works

Mechanisms and treatment of late-life depression

Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592 · see citing works

Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy

Kopschina Feltes, P., Doorduin, J., Klein, H. C., Juárez-Orozco, L. E., Dierckx, R. A., Moriguchi-Jeckel, C. M., & de Vries, E. F. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711708 · Cited by 279 · see citing works

The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation.

Dooley, L. N., Kuhlman, K. R., Robles, T. F., Eisenberger, N. I., Craske, M. G., & Bower, J. E. (2018) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.006 · Cited by 176 · see citing works

Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments

Brietzke, E. M., Mansur, R. B., Subramaniapillai, M., Balanzá‐Martínez, V., Vinberg, M., González-Pinto, A. M., Rosenblat, J. D., Ho, R., & McIntyre, R. S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.020 · Cited by 173 · see citing works

Ketogenic diet as a potential intervention for lipedema

Keith, L., Seo, C. A., Rowsemitt, C. N., Pfeffer, M., Wahi, M. M., Staggs, M., Dudek, J. E., Gower, B. A., & Carmody, M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110435 · Cited by 97 · see citing works

Cognitive behaviour therapy and inflammation: A systematic review of its relationship and the potential implications for the treatment of depression

Lopresti, A. L. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417701996 · Cited by 97 · see citing works

Visceral Inflammation and Immune Activation Stress the Brain

Holzer, P., Farzi, A., Hassan, A. M., Zenz, G., Jačan, A., & Reichmann, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01613 · Cited by 84 · see citing works

Pathomechanisms of Vascular Depression in Older Adults

Jellinger, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010308 · Cited by 78 · see citing works

Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression

Lee, Y. L., Subramaniapillai, M., Brietzke, E. M., Mansur, R. B., Ho, R., Yim, S. J., & McIntyre, R. S. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318791944 · Cited by 65 · see citing works

Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases

Brooks, A. K., Janda, T. M., Lawson, M. A., Rytych, J. L., Smith, R. A. J., Ocampo-Solis, C., & McCusker, R. H. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.010 · Cited by 42 · see citing works

The role of immunomodulators in treatment-resistant depression: case studies

Beckett, C. W., & Niklison-Chirou, M. V. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01147-6 · Cited by 41 · see citing works

The (neuro)inflammatory system in anxiety disorders and PTSD: Potential treatment targets

Sah, A., & Singewald, N. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108825 · Cited by 34 · see citing works

Neuroimmune Mechanisms and Sex/Gender-Dependent Effects in the Pathophysiology of Mental Disorders

Kokkosis, A. G., & Tsirka, S. E. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266163 · Cited by 28 · see citing works

Inflammation and Depression: A Nervous Plea for Psychiatry to Not Become Immune to Interpretation

Konsman, J. P. (2019) · Pharmaceuticals · doi:10.3390/ph12010029 · Cited by 27 · see citing works

The enigma of vascular depression in old age: a critical update

Jellinger, K. A. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02521-5 · Cited by 27 · see citing works

Depression with immuno-metabolic dysregulation: Testing pragmatic criteria to stratify patients

Zwiep, J. C., Milaneschi, Y., Giltay, E. J., Vinkers, C. H., Penninx, B. W. J. H., & Lamers, F. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.033 · Cited by 25 · see citing works

Mechanisms and treatment of late-life depression

Alexopoulos, G. S. (2021) · Focus · doi:10.1176/appi.focus.19304 · Cited by 22 · see citing works

Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers)

Conti, P., Caraffa, A., Ronconi, G., Conti, C. M., Kritas, S. K., Mastrangelo, F., Tettamanti, L., & Theoharides, T. C. (2018) · Immunologic Research · doi:10.1007/s12026-018-9004-9 · Cited by 21 · see citing works

Diet and Neurocognition in Mood Disorders - An Overview of the Overlooked

Balanzá‐Martínez, V., Shansis, F., Tatay-Manteiga, A., & López-García, P. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200318152530 · Cited by 18 · see citing works

Neither all anti-inflammatory drugs nor all doses are effective in accelerating the antidepressant-like effect of fluoxetine in an animal model of depression

Alboni, S., Benatti, C., Capone, G., Tascedda, F., & Brunello, N. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.063 · Cited by 16 · see citing works

Is There such a Thing as Post-Viral Depression?: Implications for Precision Medicine

Park, E., Shin, C. Y., Jeon, S. J., & Ham, B. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.170 · Cited by 13 · see citing works

Associations of Trauma and Posttraumatic Stress Disorder With Inflammation and Endothelial Function: On Timing, Specificity, and Mechanisms

O’Donovan, A., & Neylan, T. C. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.002 · Cited by 12 · see citing works

Treatment resistant depression in elderly

Wang, S.-C., Yokoyama, J. S., Tzeng, N., Tsai, C.-F., & Liu, M. (2023) · Progress in brain research · doi:10.1016/bs.pbr.2023.02.004 · Cited by 9 · see citing works

C-reactive protein as a biomarker for unipolar versus bipolar depression: a cross-sectional study

Dessoki, H. H., Khattab, R., Moris, W., Abdelhakim, A. A. E., Lotfy, A. M. M., & Salah, H. (2023) · Middle East Current Psychiatry · doi:10.1186/s43045-023-00342-0 · Cited by 7 · see citing works

Inflammation in Depression

Rahmawati, N. A., Karimah, A., & Amin, M. M. (2021) · Jurnal Psikiatri Surabaya · doi:10.20473/jps.v10i2.22045 · Cited by 6 · see citing works

NSAID medication mediates the causal effect of genetically predicted major depressive disorder on falls: Evidence from a Mendelian randomization study

Lv, Z., & Deng, C. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.06.028 · Cited by 3 · see citing works

Patients With Atypical Symptoms of Depression Respond Better to Lithium Augmentation Than Patients Without Atypical Symptoms

Buchbauer, H., Adli, M., Schlattmann, P., Berger, M., Bschor, T., Stamm, T., Behr, J., Ricken, R., & Buspavanich, P. (2026) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.70127 · Cited by 1 · see citing works

Exploring the Rationale for the Use of the Ketogenic Diet in the Treatment of Mental Health Disorders

Pergolizzi, J. V., Tabor, A., LeQuang, J. A., Annabi, M., & Annabi, H. M. (2019) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.1904062

5-HT2A mediated plasticity as a target in major depression: a narrative review connecting the dots from neurobiology to cognition and psychology

Bahi, C. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2007.08429

Antidepressants

(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372997.as03

Antidepressants

(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372300.as03

Chapter 3. Antidepressants

(2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551289.cd03

Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Major Depressive Disorder (MDD) Treatment

He, Q., Bennett, A. N., & Chan, K. H. K. (2025) · Springer eBooks · doi:10.1007/978-3-031-32035-4_28-1

Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Major Depressive Disorder (MDD) Treatment

He, Q., Bennett, A. N., & Chan, K. H. K. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_28

Etude de la voie de la kynurénine dans la symptomatologie du sujet obèse

Huet, L. (2019) · doi:10.70675/ff26d7c8z4c5fz4c86z9e6ezd8d843268447

Depression and anxiety in vascular dementia: an update

Jellinger, K. A. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03304-y

Research progress of anti-inflammatory agents in the treatment of major depressive disorder

Yue, D., Xiao, Y., & Xiaohong, M. (2023) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.11886/scjsws20230807001

Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials

Köhler‐Forsberg, O., N. Lydholm, C., Hjorthøj, C., Nordentoft, M., Mors, O., & Benros, M. E. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13016 · Cited by 432 · see citing works

Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder

Su, W., Hu, T., & Jiang, C. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230809112028 · Cited by 26 · see citing works

Anti-Inflammatory Treatments for Depression

Andrade, C. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19f12907 · Cited by 22 · see citing works

Comparative Efficacy and Acceptability of Anti-inflammatory Agents on Major Depressive Disorder: A Network Meta-Analysis

Hang, X., Zhang, Y., Li, J., Li, Z., Zhang, Y., Ye, X., Tang, Q., & Sun, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.691200 · Cited by 42 · see citing works